BYMED
The computed 12-month bankruptcy probability of BYMED is 4.2% (elevated). The 2024 annual accounts show equity of €7k and a net result of €-22k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €7k |
| Net result | €-22k |
| Active | 4 yrs |
| Locations | 1 |
Fragile profile, watch profitability in particular.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-10k |
| Net profit | €-22k |
| Cash flow | €-11k |
| Staff costs | - |
| Income taxes | €730 |
| Dividends | - |
| Total assets | €42k |
| Equity | €7k |
| Debt | €35k |
| of which ≤ 1y | €35k |
| of which > 1y | - |
| Working capital | €-23k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.36 |
| Quick ratio | 0.36 |
| Working capital ratio | -53.4% |
| Solvency | 17.0% |
| Debt / equity | 4.87 |
| Long-term debt ratio | - |
| Interest coverage | -15.73 |
| Gross margin | - |
| Net margin | - |
| ROA | -51.7% |
| ROE | -303.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €42k |
| Fixed assets | 21/28 | €30k |
| Tangible fixed assets | 22/27 | €27k |
| Financial fixed assets | 28 | €3k |
| Current assets | 29/58 | €13k |
| Amounts receivable within one year | 40/41 | €10k |
| Cash & bank | 54/58 | €199 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €42k |
| Equity | 10/15 | €7k |
| Contributions / capital | 10/11 | €3k |
| Accumulated profits (losses) | 14 | €4k |
| Amounts payable | 17/49 | €35k |
| Amounts payable within one year | 42/48 | €35k |
| Trade debts payable within one year | 44 | €5k |
| Income statement | ||
| Gross operating margin | 9900 | €-9k |
| Operating result | 9901 | €-21k |
| Financial income | 75 | €138 |
| Financial charges | 65 | €627 |
| Result before taxes | 9903 | €-21k |
| Income taxes | 67/77 | €730 |
| Net result for the period | 9904 | €-22k |
| Result to be appropriated | 9905 | €-22k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 23-12-2021 |
| Status | Active |
| Postal code | - |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44808H0001/00H027 | Flanders | 430 m² | 1 · 279 m² | 16.7 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | BYMED |